Over 90 Total Lots Up For Auction at One Location - WA 04/08

Molecular imaging market expands amid challenges

by Christina Hwang, Contributing Reporter | June 15, 2016
From the June 2016 issue of HealthCare Business News magazine


The Discovery IQ PET/CT by GE is designed to provide accurate quantitation with high image quality for small lesion detection, fast and efficient readings and a confident diagnosis by the physician. The Q.Clear technology that is part of the Discovery IQ offers no trade-off between image quality and quantitative standardized uptake value (SUV) measurements.

Potential new hybrid systems
New hybrid combinations such as optical/PET and optical/SPECT, along with X-ray/MR and optical/MR are being explored, and the ideas have been primarily presented at scientific talks, says Yossi Srour, president and CEO of UltraSPECT, based in Ra’anana, Israel.

According to the National Institute of Biomedical Imaging and Bioengineering, optical imaging, a noninvasive technique to look inside the body, uses visible light and special properties of photons to obtain detailed images of organs and tissues as well as cells and molecules. Quantitative measuring by SPECT or PET is not limited by tissue depth, according to research published by Joseph Culver in the Journal of Nuclear Medicine, and by combining either modality with planar optical imaging, the optical contrast data can provide high-throughput imaging of molecular and functional events, and nuclear imaging can provide the quantitative data.

Srour predicts the reading on hybrid systems will be done on the same reading system connected to PACS and hospital information systems, and all add-on software, workstations, visualization systems and CAD systems will be integrated into one huge server/cloud.

Back to HCB News

You Must Be Logged In To Post A Comment